Invention Grant
- Patent Title: Method of producing an immunoligand/payload conjugate
-
Application No.: US17839395Application Date: 2022-06-13
-
Publication No.: US11986535B2Publication Date: 2024-05-21
- Inventor: Ulf Grawunder , Roger Renzo Beerli
- Applicant: NBE Therapeutics AG
- Applicant Address: CH Basel
- Assignee: NBE THERAPEUTICS AG
- Current Assignee: NBE THERAPEUTICS AG
- Current Assignee Address: CH Basel
- Agency: Morgan, Lewis & Bockius LLP
- Priority: EP 159484 2013.03.15
- The original application number of the division: US14775374
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K47/65 ; A61K47/68 ; C07K1/107 ; C07K16/40 ; C12P21/00
Abstract:
The present invention relates to a method of producing an immunoligand/payload conjugate, which method encompasses conjugating a payload to an immunoligand by means of a sequence-specific transpeptidase, or a catalytic domain thereof (Fig. 6b).
Public/Granted literature
- US20220378927A1 METHOD OF PRODUCING AN IMMUNOLIGAND/PAYLOAD CONJUGATE Public/Granted day:2022-12-01
Information query
